Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Neelam T. Shah"'
Autor:
William Pao, Vincent A. Miller, Murk-Hein Heinemann, Mark G. Kris, Barbara Pizzo, Dana L. Sachs, Leah Ben-Porat, Leslie B. Tyson, Robert T. Heelan, Neelam T. Shah
Publikováno v:
Journal of Clinical Oncology. 23:165-174
Purpose The use of gefitinib, the first drug approved to inhibit the epidermal growth factor receptor tyrosine kinase, is indicated in patients with non–small-cell lung cancer with tumors progressive after chemotherapy. The unique mechanism of acti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::282440648706564eea3e48f7ffae5468
https://doi.org/10.1200/jco.2005.04.057
https://doi.org/10.1200/jco.2005.04.057
Autor:
Vincent A. Miller, Neelam T. Shah
Publikováno v:
Clinical Lung Cancer. 5:182-186
We present a series of cases that illustrate potential benefits of the targeted agent gefitinib for patients with advanced and heavily pretreated non-small-cell lung cancer (NSCLC). In 2 phase II clinical trials, 250 mg/day of gefitinib produced obje
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bda95ea32dee5e665639236321c51e98
https://doi.org/10.3816/clc.2003.n.032
https://doi.org/10.3816/clc.2003.n.032
Autor:
Neelam T, Shah, Jacob H, Rand
Publikováno v:
The Mount Sinai journal of medicine, New York. 70(5)
The diagnoses of thrombotic thrombocytopenic purpura (TTP) and hemolytic uremic syndrome (HUS) often remain questionable, forcing the clinician to make the difficult decision of initiating therapy based on symptomatology and clinical judgment and, so
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::18ff6a61dcffb2c74b1263c7e5a17073
https://pubmed.ncbi.nlm.nih.gov/14631521
https://pubmed.ncbi.nlm.nih.gov/14631521
Autor:
Mark G. Kris, Lee M. Krug, Vincent A. Miller, Neelam T. Shah, Jyoti D. Patel, Ennapadam Venkatraman, Jorge Gomez, Christopher G. Azzoli, Naiyer A. Rizvi
Publikováno v:
Lung Cancer. 41:S61
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ca4e4b87cabb5d270799659525284fa
https://doi.org/10.1016/s0169-5002(03)91865-4
https://doi.org/10.1016/s0169-5002(03)91865-4
Autor:
Maureen F. Zakowski, Barbara Pizzo, Neelam T. Shah, Natalie Memoli, Jyoti D. Patel, Vincent A. Miller, Mark G. Kris, David H. Johnson, Leslie B. Tyson, Robert T. Heelan
Publikováno v:
Lung Cancer. 41:S56
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::78f9fef18d7a188ec6a19ef0385b38ee
https://doi.org/10.1016/s0169-5002(03)91846-0
https://doi.org/10.1016/s0169-5002(03)91846-0